Newly created niche CRO which is the world leader in testing vaccines & antivirals through human challenge studies. Open Orphan is actively involved in the fight against COVID-19
1 Like
On the rise… 
Does anyone know why?
2 Likes
They signed a £6.8 million contract for trials, guessing that is the initiative as it’s a step closer to being profitable.
2 Likes
Wow wtf
A company i will have a read into i guess
They are certainly in demand at the moment.
https://www.asktraders.com/analysis/hvivo-shares-rallied-on-a-6-8m-rsv-contract-from-an-apac-client/
2 Likes
Great interview with ceo, from a couple of weeks ago
3 Likes